development of rapid through-put nanotoxin bioassays

16
Development of Rapid Through-put Nanotoxin Bioassays Perry Kanury Cassandra Viéville ~ Dr. Stacey Harper CBEE/EMT

Upload: yered

Post on 23-Feb-2016

29 views

Category:

Documents


0 download

DESCRIPTION

Development of Rapid Through-put Nanotoxin Bioassays. Perry Kanury Cassandra Viéville ~ Dr. Stacey Harper CBEE/EMT. Background:. Nanomaterials are widely used in both industrial and consumer applications. Currently thousands of distinct compounds in use, with more introduced every day - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Development of Rapid  Through-put Nanotoxin Bioassays

Development of Rapid Through-put Nanotoxin Bioassays

Perry KanuryCassandra Viéville ~ Dr. Stacey Harper

CBEE/EMT

Page 2: Development of Rapid  Through-put Nanotoxin Bioassays

Background:

• Nanomaterials are widely used in both industrial and consumer applications

• Currently thousands of distinct compounds in use, with more introduced every dayo Found in every day products such as deodorant, sunscreen,

Teflon, pesticides, etc.

• Little or no knowledge of the true environmental or molecular impacts of these materialso Distinct lack of methods or protocols for toxicity testing

Page 3: Development of Rapid  Through-put Nanotoxin Bioassays

What are nanomaterials?

Materials with at least one dimension between1 and 100 nanometers

o Planar: Single dimension in ‘nano’ scale Example: Graphite sheet

o Tubular: Two dimensions in ‘nano’ scale Example: Bucky Tube

o Globular: Three dimensions in ‘nano’ scale Example: Bucky Ball

Page 4: Development of Rapid  Through-put Nanotoxin Bioassays

o Subcategory of nanomaterials 

Formerly known as 'Ultra Fine Particles' At least two dimensions between 1 and 100 nanometers in diameter, implying either tubular or globular shapes Can take forms such as 'Nanoclusters', 'Nanocrystals', or 'Nanopowders' depending on agglomeration behavior

Wide range of applications including biomedical, optical and electronic fields

For reference: A typical nanoparticle has an effective diameter of approximately 1/800th that of a human hair.

What are nanoparticles?

Often exhibit unique structure-property characteristics as a result of volume to surface area ratio and surface structure

Page 5: Development of Rapid  Through-put Nanotoxin Bioassays

What does this mean to us? Wide range of possible effects to both human

and ecological systemsExamples:

Introduction of antimicrobial agents such as Aluminum Zirconium Tetrachlorohydrex (active ingredient in deodorant) into a town’s microbe-based water treatment system and subsequent watershed

Potential endocrine disruption (among additional myriad of effects) upon chronic exposure to Titanium Dioxide (active ingredient in many sunscreens) near lymph nodes, etc.

o Possible disruption of ‘Lock and Key’ hormone identification mechanisms within the Endocrine system.

Page 6: Development of Rapid  Through-put Nanotoxin Bioassays

Need:

• Rapid testing strategies are necessary to identify specific nanomaterials that result in toxicity in order to mitigate risks from exposure and define structure-property relationships that can be used to predict nanomaterial fate and hazard in lieu of empirical data.

Page 7: Development of Rapid  Through-put Nanotoxin Bioassays

Hypothesis: 

An aquatic ecosystem can be modeled in the form of a ‘nanocosm’ ~ an extremely small tritrophic ecosystem (250 uL).

Prediction:

This ecosystem can be effectively used for the purpose of assessing the toxicity of nanoparticles in aquatic environments, as well as modeling the impacts of these nanoparticles on said ecosystems.

Page 8: Development of Rapid  Through-put Nanotoxin Bioassays

Another way of looking at it:

Page 9: Development of Rapid  Through-put Nanotoxin Bioassays

Another way of looking at it:

‘Nano’ Algae    Ciliate    Bacteria

Varying nanoparticle exposures

(All 3 organisms)

Page 10: Development of Rapid  Through-put Nanotoxin Bioassays

o Tri-trophic aquatic ecosystem based upon our local temperate region Photo-synthesizer (primary producer):

Chlamydomonas reinhardtii (green algae) Predator (primary consumer): Tetrahymena

thermophilia (ciliate) Decomposer (detritovore): E.coli (bacteria)

o Suspended in a defined microbial mediao Upon exposure by nanotoxins, can monitor

population dynamics and predator/prey interactions to understand effects. Varying nanoparticle exposures

The makeup and utilization of a Nanocosm:

‘Nano’ Algae   Ciliate    Bacteria(All 3 organisms)

Page 11: Development of Rapid  Through-put Nanotoxin Bioassays

Typical Plate Layout

0.01 ppm

0.05 ppm

0.1 ppm

0.5 ppm

1 ppm

5 ppm

10 ppm

50 ppm

Nano Bacteria Algae Ciliate

Three replicates of each treatment for each organism

Exposure Concentration

Page 12: Development of Rapid  Through-put Nanotoxin Bioassays

How we observe these interactions:

Flow Cytometer

Cell Concentration (cells/uL) of each organism are obtained and analyzed based upon effective size and fluorescence.

Quantifies and categorizes cells via light diffraction and  fluorescence. 

‘Nano’ Algae   Ciliate    Bacteria(All 3 organisms)

Varying nanoparticle exposures

Page 13: Development of Rapid  Through-put Nanotoxin Bioassays

How we observe these interactions:

Tetrahymena Thermophilia AgNO3 Exposure over 5 days

Page 14: Development of Rapid  Through-put Nanotoxin Bioassays

Treatment is observed relative to negative control within the same timepoint (((treatment-control)/control)*100)

How we observe these interactions:

Concentration Response

Page 15: Development of Rapid  Through-put Nanotoxin Bioassays

Future Work:

• Investigation of more ideal organisms than Tetrahymena thermophilia in order to streamline data collection utilizing existing equipment

• Investigation of additional endpoints beyond mortality• Investigation of possible mechanisms of toxicity• Establishment of a database of the effects of various

nanotoxin exposures.

Page 16: Development of Rapid  Through-put Nanotoxin Bioassays

Acknowledgements:

• Dr. Stacey Harper • Cassandra Viéville• Howard Hughes Medical Institute• Environmental Health Sciences Center (EHSC)• Oregon State University• Dr. Kevin Ahern